Absci· abscibio·· 26 天前AI 评分34
Absci的ABS-201女性脱发临床试验队列开放
Our ABS-201 program for pattern hair loss was recently featured in Bustle, covering the opening of a dedicated women’s cohort in our Phas...
AI 导读
Absci的ABS-201项目在1/2a期临床试验中开设了专门的女性队列，用于治疗模式性脱发。ABS-201是AI设计的抗PRLR抗体，Absci称其有望成为近三十年来雄激素性脱发首个新作用机制。公司近期公布了HEADLINE试验的1期积极中期数据。
来源：Absci · x.com